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A B S T R A C TCytokines are cell signalling proteins that mediate a number of different physiological responses. The accurate
measurement of cytokine proﬁles is important for a variety of diagnostic and prognostic scenarios in relation to
animal health and welfare. Simultaneous quantiﬁcation of cytokine proﬁles in a single sample is now possible
using ﬂuorescent microsphere immunoassays (FMIA). We describe the development and validation of a novel
multiplex assay using the Bio-Plex1 200 system to quantify cytokines in ﬁve different porcine tissues (brain,
placenta, synovial tissue and ﬂuid, plasma). The cytokine proﬁles are both tissue, and research hypothesis,
-dependent but include Interleukin-1beta (IL-1β), Interleukin-4 (IL-4), Interleukin-6 (IL-6), Interleukin-8 (IL-8),
Interleukin-10 (IL-10) and Tumor necrosis factor (TNF-α).
This methods paper is reported in two parts: the development of a FMIA for porcine tissues and validation of
pre-treatment for optimal cytokine recovery in porcine brain, placenta, synovial tissue and plasma. Validation
steps are critical in ensuring an assay is suitable for novel sample types.
This technique advances traditional ELISAs by:
 FMIA provides insight into the proﬁles of multiple porcine cytokines in certain situations (e.g. disease,
parturition).
 Use of the Bio-Plex1 200 system to investigate novel sample types, including brain, placenta and synovial
tissue.
 Multiplexing utilises a fraction of the sample volume compared with multiple ELISAs.Ca
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Subject Area: Agricultural and Biological Sciences
More speciﬁc subject area: Animal health and biomarker detection
Method name: Fluorescent Microsphere Immunoassay (FMIA)
Name and reference of
original method:Bjerre,M., Hansen,T.K., Flyvbjerg,A. and Tonnesen,E., 2009. Simultaneous detection of
porcine cytokines by multiplex analysis: Development of magnetic bioplexResource availability: Bio-Plex 200 Hardware: Bio-Rad – Bio-Rad, UK
Software: Bio-Plex Manager v6.1 – Bio-Rad UK
All reagents for Bio-Plex from Bio-Rad, UK
MagRack 6 (GE Healthcare)
Optional: Bio-Plex Pro II Wash Station - Bio-Rad, UK
Antibodies – RnD systems (https://www.rndsystems.com/)
Other chemicals and reagents – Sigma, ThermoFisher, GibcoMethod details
Part 1 development of ﬂuorescent microsphere immunoassay (FMIA)
Covalent coupling of capture antibodies to magnetic carboxylated microspheres
For each cytokine, the relevant capture antibody was coupled following manufacturer’s instructions,
using reagents from the Bio-Plex amine coupling kit (Bio-Rad, UK) except where speciﬁed. All reagents
were brought to room temperature (RT) before use. Brieﬂy, 100 ml (1.25 106 microspheres) of
ﬂuorescently distinct microspheres (beads) were separated from the supernatant using a magnetic
separator and washed in 100 ml bead wash buffer by vortexing for 30 seconds (s). The supernatant was
removed by magnetic separation again and then the washed beads were resuspended in 80 ml of bead
activation buffer by vortexing for 30 s. To this, 10 ml of S-NHS (50 mg/ml; Fisher, UK) and 10 ml of EDC
(50 mg/ml; Fisher, UK) prepared in bead activation buffer were added and mixed gently by vortexing. The
tube was incubated in the dark with shaking for 20 min at room temperature (RT). After incubation,100
ml phosphate buffered saline (PBS; pH 7.4) was added and vortexed for 10 s. The supernatant was
removed by magnetic separation and the PBS wash step repeated. The beads were then resuspended in
100 ml PBS and vortexed for 30 s. The recombinant cytokine proteinwas added to the activated beads and
mixed by vortexing and then incubated for 2 h in the dark at RT with shaking.
The supernatant was removed by magnetic separation, using a MagRack 6 (GE Healthcare) and
coupled beads were resuspended in 500 ml PBS. The supernatant was again removed, and beads were
resuspended in 250 ml of blocking buffer, vortexed for 15 s. and incubated in the dark at RT for 30 min
with shaking. The supernatant was removed by magnetic separation and beads were resuspended in
500 ml of storage buffer. Further concentration of the beads was obtained when the supernatant was
removed by magnetic separation and then coupled beads were resuspended in 150 ml of storage
buffer. The bead concentration was determined using an automated cell counter (TC10 Bio-Rad, UK).
The coupled beads were stored in the dark at 2–8 C until use.
Singleplex and multiplex procedures
Capture and detection antibodies and recombinant cytokines were purchased as matched pairs if
available which were commercially validated for binding to different epitopes on the antigen (Table 1).
Table 1
Antibodies (with optimised concentrations), standards and beads used for each cytokine in the multiplex assay.
Analyte Reagent Catalogue # Description/bead region Optimised antibody
concentration (mg/ml)/
bead region
Source
IL-1β Capture Ab MAB6811 Mouse anti-porcine 20 R&D systems
Detection Ab BAF681 Biotinylated goat anti-porcine 0.5 R&D systems
Standard 681-PI Recombinant Porcine IL-1 beta – R&D systems
Bead MC10029 Pro Magnetic COOH Beads 29 29 Bio-Rad
IL-4 Capture Ab AF654 BAF654 Goat anti-porcine 20 R&D systems
Detection Ab 654-P4 Biotinylated goat anti-porcine 0.75 R&D systems
Standard MC10064 Recombinant Porcine IL-4 – R&D systems
Bead Pro Magnetic COOH Beads 64 64 Bio-Rad
IL-6 Capture Ab AF686 BAF686 Goat anti-porcine 20 R&D systems
Detection Ab 686-PI Biotinylated goat anti-porcine 0.5 R&D systems
Standard MC10026 Recombinant Porcine IL-6 – R&D systems
Bead Pro Magnetic COOH Beads 26 26 Bio-Rad
IL-8 Capture Ab MAB5351 BAF535 Mouse anti-porcine 20 R&D systems
Detection Ab 535-IN Biotinylated goat anti-porcine 0.5 R&D systems
Standard MC10045 Recombinant Porcine IL-8 – R&D systems
Bead Pro Magnetic COOH Beads 45 45 Bio-Rad
IL-10 Capture Ab MAB693 BAF693 Mouse anti-porcine 20 R&D systems
Detection Ab 693-PI Biotinylated goat anti-porcine 0.5 R&D systems
Standard MC10035 Recombinant Porcine IL-10 – R&D systems
Bead Pro Magnetic COOH Beads 35 35 Bio-Rad
TNF-α Capture Ab MAB690 BAF690 Mouse anti-porcine 20 R&D systems
Detection Ab 690-PT Biotinylated goat anti-porcine 0.5 R&D systems
Standard MC10055 Recombinant Porcine TNF-α – R&D systems
Bead Pro Magnetic COOH Beads 55 55 Bio-Rad
Ab: antibody, Source: R&D Systems, (Abingdon, UK), Bio-Rad, (Hemel Hempstead, UK).
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cross-reactivity with other cytokines. Individual cytokine measurements were initially optimised as a
singleplex for IL-1β, IL-4 IL-6, IL-8, IL-10, TNF-α) before combining them to perform a multiplex, which
was then further optimised. Optimisations included the amount of capture antibody coupled to
magnetic microspheres, detection antibody concentration, incubation time and assay buffer matrix.
Optimal antibody (capture and detection) concentrations are summarised in Table 1. The optimal
assay buffer used was 81% distilled water, 10% Reagent diluent (R&D systems, UK) and 9% heat
inactivated foetal calf serum (Gibco, UK). For the FMIA, 50ml of magnetic microspheres coupled with
20 mg/ml of capture antibody were ﬁrst added to a 96 well, black, ﬂat-bottomed plate and washed
twice with wash buffer using a Bio-Plex Pro II Wash Station (Bio-Rad, UK). To this, 50 ml of prepared
recombinant standards, unknown samples, controls or blanks (assay buffer only) were added. The
plate was then incubated in the dark with shaking at RT for 2 h. To reduce bubbles from forming (and
beads from sticking to sides) during incubation a high shaking setting (900–1100 rpm) was used for
ﬁrst 30 s then lower (300 rpm) for the rest of the incubation time. The plate was washed three times as
before, then 100 ml of the detection antibody (in assay buffer) was added to the wells and the plate was
incubated as before for 40 min. The plate was washed three times as previously, then 50 ml of diluted
Streptavidin-PE solution (Bio-Rad) was added and the plate was incubated for a further 20 min. The
plate was washed for a ﬁnal three times, and then 125 ml of assay buffer was added. The plate was
incubated with shaking for 5 min then the reaction was measured using a Bio-Plex 2001 instrument
and analysed with the Bio-Plex Manager software version 6.1. For details of measurements taken
during the run see Hall et al. [1]. The instrument was calibrated daily and validated monthly using
bead standards (Bio-Rad). Mean Fluorescent Intensity (MFI) for 100 microspheres corresponding to
each individual cytokine analyte was recorded for each well. All reported MFI measurements were
background corrected by the software (normalised) (F  Fo), where Fo was the background signal
determined from the ﬂuorescence measurement of the blank. The standard curve was produced using
logistic 5PL regression where recovery was in the 70–130% range as previously deemed acceptable [2].
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Each cytokine (singleplex) was optimised individually and validated as below before an additional
cytokine was added sequentially form a multiplex. The FMIA assays were validated using a number of
measures.
Assay range and sensitivity: These were the concentrations as measured and reported by the Bio-
Plex Manager software on completion of the assay run.
Recovery: For each cytokine standard the recovery of known amounts of cytokines (range 10,000–
40.06 pg/ml) had to be within the 70–130% range to be included as successful detection [2]. In
addition, samples were spiked with known amounts of cytokine to calculate spiked recovery. This also
had to be within the 70–130% range.
Repeatability: To verify the repeatability of the assay, dilutions of recombinant cytokine standards
were prepared for each cytokine and used in triplicate in the FMIA over a 3-day period of time [3] and
expressed as inter and intra-assay variation. The determination of intra-assay repeatability was
evaluated by analysing multiple replicates (n = 3) of seven recombinant cytokine standards with
known concentrations during a single assay run and expressed as the coefﬁcient of variation (CV) of
repeated measurements. Inter-assay variability was studied using seven different concentrations of
standards, analysed in triplicate over three different days and expressed as the CV of repeated
measurements [3].
Cross-reactivity (speciﬁcity): A multiplex FMIA was set up with standards containing all capture
and detection antibodies and all recombinant cytokines. Unknown wells contained all capture
antibodies and cytokine recombinants but only one detection antibody to test speciﬁcity for each
matched pair of antibodies. Cross reactivity was deﬁned as the percentage of nonspeciﬁc, cross
reacting signal detected relative to the speciﬁc signal for that analyte.
Part 2 extraction of cytokines from porcine tissues
Brain tissue
Porcine brain samples were collected as part of a previous study and stored at 80 C [4] and
prepared using a modiﬁcation of procedures described by Hulse et al. [4]. The hippocampus from the
left hemisphere was removed from a brain slice of each pig (n = 14), weighed, crushed to a powder
with liquid nitrogen and transferred to a 1.5 ml microtube. To this, 500 ml of cell lysis buffer (Bio-Rad,
UK) with 1 ml stock solution was added and homogenised with a hand-held homogeniser (VWR
VDI12). The total protein content was measured using Quick Start Bradford Protein Assay (Bio-Rad,
UK) according to manufacturer’s instructions (Bio-Rad Quick start Bradford Assay) [5]. Brain extracts
were frozen in aliquots (individually and equally pooled) at 80 C pending FMIA analysis. Pooled
extracts were spiked (with 4000 pg/ml) with both individual cytokines and a mixture of all six
cytokines and then also diluted 2.5 fold, to validate the assay, ensuring recovery was always within
70–130% range.
Placenta
Pig placenta tissue was collected as part of a previous studyand stored at 80 C [6] and was extracted
by the same methodas the brain tissueabove.Forboth tissuestypes, before analysis samples were pooled
and both pooled and pooled-spiked (with 4000 pg/ml cytokines) samples were serially diluted six times
(2.5 fold dilutions) and percentage recoveries were calculated for all dilutions.
Synovial tissue
Synovial tissue (ST) was collected from a pig model of spontaneous joint disease and lameness
where a cytokine response was being investigated [7]. Synovial samples were collected from the knee
joints of ‘Landrace  Duroc  Large White’ female pigs of different ages. Following humane euthanasia
the knee joint was carefully opened and aseptic aspiration was used to obtain a sample of synovial
ﬂuid, before a lateral or frontal joint capsule sample was excised and the surface of the articular
cartilage examined. A sample of joint synovial tissue was taken at the site of excision. Synovial tissue
samples (approx. 1 g) and synovial ﬂuid were rapidly frozen on dry ice in DNase/RNase-free 2 ml
cryovials and stored at 80 C pending analysis.
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buffer, (2) cell lysis buffer and (3) phosphate-buffered saline (PBS) for the recovery and quantiﬁcation
of three cytokines (IL-1β, IL-6 and TNFα) using the FMIA.
For RIPA buffer extraction, approximately 0.3 g of synovial tissue was homogenised on ice in RIPA
lysis buffer (3 ml) (Alpha Diagnostics #RIPA-50 lysis buffer kit for mammalian cell lysis buffer with
protease phosphatase inhibitors cocktail) and left to fully solubilize the tissue proteins for 2 h on ice
(following manufacturer’s guidelines). Synovial tissue lysates and synovial ﬂuid supernatants were
obtained following centrifugation of the homogenates at 3000  g for 20 min at 4 C. All lysates and
supernatants were carefully pipetted off and transferred to new cryovial tubes and stored at 80 C
pending immunoassay analysis.
Cell lysis buffer extraction involved [5] further synovial tissue samples homogenised in lysis buffer
with protease inhibitors. Protease Inhibitor Cocktail lyophilised powder (Sigma-Aldrich, catalogue #
P2714) was reconstituted with Tissue Extraction Reagent I (lysis buffer) (Invitrogen, catalogue #
FNN0071) just before use. After reconstitution, the solution is stable for 24 h at 4 C, therefore aliquots
were made for immediate use and freezing. 0.1 g of tissue was weighed per sample and homogenised
as in the above procedure in a ﬁnal volume of 1 ml buffer. Homogenates were centrifuged at 5000  g
for 5 min (4 C), according to the manufacturer’s instructions, and aliquoted and frozen as above.
For PBS cytokine extraction, approximately 200 mg of synovial tissue was added to 2 ml x1 PBS and
homogenised over ice using a hand-held homogeniser (VWR VDI12). Samples then underwent two
freeze-thaw cycles before centrifuging at 5000  g for 5 min. Supernatants were collected, aliquoted
and immediately frozen. Some samples required a second centrifugation due to fat globules remaining
in the supernatant. We tested recovery of spiked samples for each extraction method (RIPA, cell lysis,
PBS) by spiking with a known concentration of cytokine standards (4000 pg/ml) and RIPA buffer
extracted samples were also diluted 1:2, 4 and 8 to test for dilution effects.
Protein concentration of the all lysates was measured using a Bradford assay according to
manufacturer’s instructions (Bio-Rad Quick start Bradford Assay) as before.
Synovial ﬂuid
Synovial ﬂuid (SF) is a non-newtonian ﬂuid with a complex matrix including hyaluronic acid,
lubricin, proteinases, and collagenases. It may also contain rheumatoid factor (RF) and heterophilic
antibodies [8,9]. SF was collected at the same time as the synovial tissue (see above). For validation
experiments, a pool of SF from four pig samples was prepared. It was centrifuged at 1000  g for
15 min. and supernatant used.
For the recovery and quantiﬁcation of three cytokines (IL-1β, IL-6 and TNFα) using the FMIA, we
tested recovery of spiked samples following dilution (neat, 1:2, 4, 8), hyaluronidase treatment,
centrifugal concentration using vivaspin ﬁlter columns and incubation with a blocking buffer.
For hyaluronidase treatment we added 2 mg/ml hyaluronidase (sigma catalogue H3506) in 0.02 M
PBS to the SF and incubated for 1 h at RT [10].
In an attempt to ﬁlter out the larger molecules such as hyaluronan, chondroitin sulphate and
keratan sulphate [10] from the SF we used vivaspin columns (Sartorius vivaspin 500 columns,
50KMWCO, PES membrane). SF (was loaded onto the ﬁlter and centrifuged at 14,000  g for 9 min.
Samples were spiked before (pre) and after (post) ﬁltering with the columns with a known
concentration of cytokine standards (4000 pg/ml). They were also diluted by 1: 2, 5, 10, 20, 40 to
ascertain any dilution effects.
In an attempt to block antibodies and RF interference which can cause capture and detection
antibodies to crosslink [8,11], a pooled SF sample was also incubated with a blocking buffer of either
bovine plasma (Biosera) or a 1:1 equine and caprine serum (Sigma-Aldrich). Synovial ﬂuid was
incubated (1:1) for 30 min at RT before centrifuging at 1000  g for 15 min.
Blood plasma
Blood was collected from pigs post-farrowing from tail or ear veins, as part of a separate study
investigating post-partum biomarkers of inﬂammation [12].
A 6 ml EDTA vacutainer (Henry Schein Animal Health, Dumfries, Dumfries and Galloway, UK) was
used to collect a blood sample. For more detailed methodology see Ison et al. [12]. Blood was
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for 15 min at 1400  g. Plasma was pipetted into four 1.5 ml pre-labelled tubes and frozen at 80 C to
be assayed at a later date. Samples were removed from the 80 C freezer on the morning of the assay,
put on ice to defrost then three pooled samples were created. These were analysed for three cytokines
(IL-1β, IL-6, TNF-α) neat and diluted 1:2 following previous results with plasma [2]. In addition, we
analysed the pooled samples spiked with known concentrations of cytokines at high (4000 pg/ml) and
low (640 pg/ml) and diluted 1:2 for spiked recovery calculations.
Method validation results
Part 1 development of multiplex assay
Singleplex FMIA were developed for IL-1β, IL-4, IL-6, Il-8, IL-10 and TNFα which were then
combined into a 6-plex. The selection of cytokines was based on their role as welfare and pain
biomarkers [13]. These cytokines were chosen to produce a broad proﬁle of cytokines with both pro-
and anti-inﬂammatory roles, but were also constrained by commercial availability of porcine
antibodies.
Standard curves (MFI versus concentration) following a 2.5 fold dilution for each cytokine followed a
similar trend for both singleplex and 6-plex however ﬂuorescence was higher in 6-plex compared to
singleplexfor IL-4, IL-6, IL-10andTNFα, buttheconversewasseenfor IL-1βandIL-8(Fig.1). Thismayindicate
a change in sensitivity, which may be due to the increase in microspheres present. MFI values were very
different for each cytokine over the standard range, with maximum MFI ranging from 800 to 14,000 (Fig.1).
The 6-plex had a range over 4 logs from 10,000 to 40.96 pg/ml for each cytokine except IL-1β (lower
102.40 pg/ml) which is comparable to previous assays [2] and covers the range of cytokines detected in
porcine serum [3]. Inter and intra-assay variation was low for all cytokines (<7%), which was an
improvement over previous assays (3–18%) [2,3] (Table 2).
Cross reactivity
Singleplex reactions for each of the six cytokines were checked systematically against the other
cytokine reactions to ensure they were speciﬁc. No cross reactivity was observed for any of the 6-plex
cytokine reactions (Table 2), which ensures that there will be no false positive results when samples
are analysed with the multiplex.
Part 2 detection of cytokines in porcine tissue
Brain
A mean of 9.36 mg/ml (0.91) of protein was extracted from brain tissue using the cell lysis
method. Three cytokines were detected in the brain samples, with spiked recovery within the 70–
130% range, with average concentrations of pooled samples: IL-1β (301.98 pg/ml CV% 2.32%), IL-6
(16.03 pg/ml, CV% 3.65) and IL-10 (9.65 pg/ml CV% 10.88).The levels of other cytokines (IL-4, IL-8 and
TNF-α) were all below the level of detection of the FMIA. Dilution of spiked pooled sample by
1:2.5 gave the optimum percentage recovery, with an average of 91% (s.e.m 13.3).
Placenta
A mean of 6.40 mg/ml (0.63) of protein was extracted from placenta using the cell lysis method.
Porcine placenta cytokine levels were assessed using the 6-plex. Initially, placenta and spiked
samples of ‘normal’ and ‘small’ placenta were run at four dilutions (2.5 fold serial dilutions). A
dilution of 1:2.5 gave the optimum percentage recovery across all cytokines, with an average of 117%
recovery (s.e.m 24.0). Three cytokines were present in measurable amounts in placental samples
IL-1β (median 265.63 pg/ml, range 187.05–344.2), IL-6 (4169.41 pg/ml range 3223.57–4169.41), IL-8
(258.26 pg/ml, range 147.58–368.94). The other three cytokines (IL-4, IL-10 and TNF-α) were below
the level of detection (see Table 2 for minimum range for each cytokine) in these particular placenta
samples. There were no Bio-Plex sample errors, such as low bead number for either placenta or brain
tissue (data not shown).
Fig. 1. Standard curves for singleplex (squares) and 6-plex (diamonds) for each of the six cytokines IL-1β, IL-4, IL-6, Il-8, IL-
10 and TNFα shown by mean ﬂuorescent intensity (MFI) for seven serially diluted recombinant cytokine standards. Numbers in
parantheses are Luminex microsphere (bead) numbers used.
Table 2
Validation of porcine six-plex assay. Assay range of detection, sensitivity, intra- and inter-assay variation and assay speciﬁcity (%
cross reactivity).
Target cytokine
(bead region)
Assay range
(pg/ml)
Sensitivity
(pg/ml)
Intra-
assay (%
CV)
Inter-
assay (%
CV)
Cross reactivity (%)
min max IL-1β IL-4 IL-6 IL-8 IL-10 TNF-α
IL-1β (29) 102.40 10,000 97.55 3.72 3.75 107.96 0.50 0.50 0.21 0.35 0.00
IL-4 (64) 40.96 10,000 36.07 5.10 5.25 0.50 98.10 0.80 0.50 0.60 0.60
IL-6 (26) 40.96 10,000 40.53 3.73 4.14 1.46 0.83 110.29 0.59 0.39 1.40
IL-8 (45) 40.96 10,000 42.05 4.81 5.65 1.42 0.51 0.49 97.51 0.34 0.51
IL-10 (35) 40.96 10,000 40.58 4.10 4.15 1.40 0.62 0.45 0.18 108.07 0.26
TNF-α (55) 40.96 10,000 38.64 4.64 4.95 1.21 0.62 0.44 0.18 0.31 101.96
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Of the three pre-treatment extraction methods used to extract cytokines from synovial tissue, (RIPA,
cell lysis buffer and PBS) there was a range of recoveries observed (Table 3). The extraction method
appeared to differentially affect the recoveries of each of the three cytokines tested (IL-1β, IL-6 and TNFα)
Table 3
Synovial tissue comparison of spiked recoveries (with 4000 pg/ml) for extraction with RIPA buffer (diluted 2, 4, 8), cell lysis
buffer and PBS. Italicised numbers represents unacceptable recoveries (out with 70–130%).
Synovial
Tissue
RIPA buffer Cell lysis buffer PBS extraction
Cytokine Dilution 1:2 spiked
sample % recovery
Dilution 1:4 spiked
sample % recovery
Dilution 1:8 spiked
sample % recovery
Spiked sample
% recovery
Spiked sample %
recovery
IL-1β 49 57 62 49 89
IL-6 96 89 86 44 130
TNF-α 16 75 84 13 94
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analytes in an assay. The highest recoveries were seen with PBS buffer (IL-1β 89%, IL-6 130% and TNFα
94%), so this method was chosen for subsequent analyses.
Synovial ﬂuid
Four pre-treatments were tested with SF (dilution in assay buffer, hyaluronidase treatment,
viva spin columns and incubation with serum). During the process of assay validation, it was
discovered that the recovery of known concentrations of cytokines in spiked samples of SF was
very variable and consistently <50% (range 11–48% with optimal dilutions for all cytokines). SF
was initially diluted to reduce the ﬂuid’s viscosity, and potential interference from antibody/
rheumatoid factors present, however for the three cytokines tested (IL-1β, IL-6 and TNFα) the
spiked recoveries ranged from 7 to 48%. Comparison of incubating with and without
hyaluronidase, only increased recovery from 8 to 23% (low spike) and 22 to 29% high spike.
Spin column recoveries were also inadequate as columns appeared to ﬁlter out cytokines as well
as molecules that were interfering with the assay, with spiked recoveries only improving if
cytokine was added after the column ﬁltration. Incubation of SF with bovine plasma improved
spike detection by 10–55% and incubation with horse/goat serum improved spike detection by 14–
45%. To date, none of these approaches has yielded signiﬁcantly improved analyte recovery or
identiﬁed the most effective pre-treatment for SF. Further work on the SF samples is on-going to
resolve analyte recovery, and reliability and repeatability of measurement. Detail of speciﬁc
recoveries for each test in Supplementary material (Tables 5–8).
Blood plasma
Plasma was chosen for validation rather than serum due to previous inconsistencies observed
while validating cytokines in horse blood [1]. All three cytokines (IL-1β, IL-6, TNF-α) were detected in
neat pooled samples but diluting 1:2 resulted in levels close to the lowest level of detection and
unacceptable percentage recovery values for TNF-α (Table 4). Moreover, pooled plasma spiked with
known cytokines resulted in acceptable recoveries if run neat however resulted in poor recovery
values when diluted 1:2 (Table 4). Therefore, porcine plasma samples were analysed neat for all
further plasma cytokine measurements in pigs.Table 4
Average percentage recoveries for pooled samples of plasma (diluted 1:2) and spiked with high (4000 pg/ml) and low (640 pg/
ml) cytokines. Italicised numbers represents unacceptable recoveries (out with 70–130%).
Average % recovery Average % recovery Average % recovery
Dilution IL-1β IL-6 TNF-α
Spiked plasma HIGH (4000 pg/ml) 1 102 100 106
Spiked plasma LOW (640 pg/ml) 1 95 101 111
Spiked plasma HIGH (4000 pg/ml) 2 105 125 135
Spiked plasma LOW (640 pg/ml) 2 109 168 219
Pooled samples 2 106 97 66
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The development of this robust yet ﬂexible FMIA assay, which has improved sensitivity over
previous assays, is capable of measuring multiple cytokines simultaneously in porcine biological
samples. Wyns et al. [14] reported that bead-based assays are more efﬁcient at capturing soluble
antigens than surface-coated ELISAs. Overall, our standard curve range and assay sensitivity is
similar to previous FMIA and covers a wider range than many commercial ELISA kits [2,15] and we
have shown its use with a wider range of sample types. The standard curve range of IL-1β, in this
multiplex has a reduced sensitivity compared to the other analytes, however this has been
observed previously [3], which allows us to measure porcine plasma without need for dilution.
This assay will reduce sample volume, time and cost associated with single ELISAs yet also
providing a more comprehensive picture of the suite of cytokines produced in different tissues,
allowing investigation into immunological response to speciﬁc challenges. The added value of this
tool is its potential, following appropriate validation steps, to have additional cytokines of interest
added. The panel of cytokines chosen for FMIA should be biologically relevant to the research
question being asked. This porcine assay, validated for use in brain, placenta, synovial tissue
lysates and plasma adds to the laboratory toolbox for this increasingly utilised animal model for
biomedical science research.
The extraction part of this assay development has highlighted how caution should be taken when
working with previously untested biological samples, such as synovial ﬂuid and the importance of
validation of any novel assay. We did not observe the same recovery values as [10] for treated SF,
therefore we do not use this assay for this sample type at present. In our attempts to measure
cytokines in synovial ﬂuid we did an extensive literature review to better understand any sample pre-
treatment required. In the majority of published reports the analyte recovery data was often lacking or
not discussed and this highlights the importance of internal validation in order to obtain reliable and
consistent results.
This technical note describes a FMIA protocol for measurement of multiple cytokines in porcine
samples and the different pre-FMIA extraction methods required for optimal analyte recovery and
quantiﬁcation.
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